Times are stated in CEST (GMT + 2 / UTC + 2)
Every effort has been made to convert the IPVC 2020 scientific program into a fully virtual program. Thank you to all the presenters who have submitted their recordings in advance. These are available as on-demand webcasts in the interactive program on the virtual conference platform. Please note that some presenters were not able to pre-record their presentations, therefore there are still some sessions with missing presentations.

To view the pre-conference workshops, you need to register for them separately. Please contact: reg_ipvc20@kenes.com
You will then receive an email with instructions on how to login to the workshops’ platform. 

Displaying One Session

View
Clinical Science Oral Session

00620 - Oral Session 3: Clinical Aspects of Cervical Prevention and Treatment (ID 75)

Session Type
Clinical Science Oral Session
Session Date
07/22/2020
Session Time
07:45 - 08:35
Room
Hall C
Chair(s)

Session Webcast

Oral Session 3: Clinical Aspects of Cervical Prevention and Treatment Hall C

IMMUNOGENICITY AND SAFETY OF A NINE-VALENT HUMAN PAPILLOMAVIRUS VACCINE IN WOMEN AGED 27–45 YEARS VERSUS 16–26 YEARS: AN OPEN-LABEL PHASE 3 TRIAL (ID 1306)

Session Date
07/22/2020
Session Time
07:45 - 08:35
Room
Hall C
Session Type
Clinical Science Oral Session
Session Name
Oral Session 3: Clinical Aspects of Cervical Prevention and Treatment
Lecture Time
07:45 - 07:57
Presenter
Authors

Webcast

[session]
[presentation]
[presenter]
Hide
Oral Session 3: Clinical Aspects of Cervical Prevention and Treatment Hall C

COMPARISON OF TITERS IN THE GARDASIL IMMUNOGENICITY WITH NEEDLE-FREE INJECTION TRIAL AND THE COSTA RICA HPV VACCINE TRIAL SUGGEST CLINICAL PROTECTION BY NEEDLE-FREE INJECTION (ID 1107)

Session Date
07/22/2020
Session Time
07:45 - 08:35
Room
Hall C
Session Type
Clinical Science Oral Session
Session Name
Oral Session 3: Clinical Aspects of Cervical Prevention and Treatment
Lecture Time
07:57 - 08:09
Presenter
Authors

Webcast

[session]
[presentation]
[presenter]
Hide
Oral Session 3: Clinical Aspects of Cervical Prevention and Treatment Hall C

VAGINAL SELF-SAMPLING EQUIVALENT TO ASSISTED SAMPLING IN HPV PREVALENCE AND DETECED CIN2+ FOR SAMPLES APPLIED TO THE FTA CARD AND ANALYZED WITH THE HPVIR TEST (ID 311)

Session Date
07/22/2020
Session Time
07:45 - 08:35
Room
Hall C
Session Type
Clinical Science Oral Session
Session Name
Oral Session 3: Clinical Aspects of Cervical Prevention and Treatment
Lecture Time
08:09 - 08:21
Presenter
Authors

Webcast

[session]
[presentation]
[presenter]
Hide
Oral Session 3: Clinical Aspects of Cervical Prevention and Treatment Hall C

CLEARANCE OF HSIL AND MODULATION OF IMMUNE RESPONSES TO HPV ONCOGENES WITH LOW DOSE POMALIDOMIDE: A PHASE II STUDY IN INDIVIDUALS WITH PERSISTENT ANAL HSIL (ID 1138)

Session Date
07/22/2020
Session Time
07:45 - 08:35
Room
Hall C
Session Type
Clinical Science Oral Session
Session Name
Oral Session 3: Clinical Aspects of Cervical Prevention and Treatment
Lecture Time
08:21 - 08:33
Presenter
Authors
Oral Session 3: Clinical Aspects of Cervical Prevention and Treatment Hall C

Online Chat Q&A for this session is called: CLINICAL SCIENCE ORAL SESSION 3: CLINICAL ASPECTS OF CERVICAL PREVENTION AND TREATMENT. You can join the online chat Q&A and discussions for this session by going back to the Lobby and entering the Networking Lounge. Speakers are encouraged to be online in the chat room at the time this session is stated to end. All times are in CEST. (ID 1785)

Session Date
07/22/2020
Session Time
07:45 - 08:35
Room
Hall C
Session Type
Clinical Science Oral Session
Session Name
Oral Session 3: Clinical Aspects of Cervical Prevention and Treatment
Lecture Time
08:33 - 08:33